MBOT News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

MB

Mkt Cap

$63.9M

Volume

785.80K

Next Earnings

November 11th

Loading chart

MB

MBOTMicrobot Medical, Inc. Common Stock

MBOT

Pay with—

Available Balance0.00

MB

Mkt Cap

$63.8M

Volume

785.80K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Microbot Medical® Highlights Growth StrategyMicrobot Medical (NASDAQ: MBOT) announced expansion of its LIBERTY robotic system across the U.S., securing its first California customer and expanding into North Carolina. The company is on track to establish 12 sales territories by year-end, hired additional sales leadership, and expects positive gross margins in 2027 through manufacturing efficiencies. International expansion into Asia and Middle East is in advanced stages with CE mark approval expected in late Q4 2026 or early Q1 2027.GlobeNewswire Inc. · Sep 25, 2026

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable ValueThe healthcare sector is shifting toward outpatient clinics and ambulatory services, with AI-powered diagnostics and remote care technologies gaining significant traction. Multiple medtech companies are advancing innovative solutions: VentriPoint Diagnostics is expanding cardiac imaging to remote communities via partnership with First Light Health; Senseonics demonstrated strong real-world data for its year-long continuous glucose monitor; Microbot Medical achieved clinical milestones with its robotic endovascular system; LivaNova received FDA approval for its sleep apnea treatment device; and Clover Health showed AI-assisted primary care reduces hospitalizations in high-risk patients.Benzinga · Mar 27, 2026

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical EventMicrobot Medical announced that its operations in the USA and Israel remain unaffected by current geopolitical events. The company is proceeding with its commercial expansion of the LIBERTY Endovascular Robotic System, including hiring additional sales representatives and a Director of HEOR. The company plans a full market release at the Society of Interventional Radiology conference in April 2026 and maintains sufficient U.S. inventory to support current and anticipated demand.GlobeNewswire Inc. · Mar 3, 2026

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross ProceedsMicrobot Medical completed a three-tranche preferred investment option exercise, raising approximately $29.2 million in gross proceeds, with potential additional proceeds of $63 million from future option exercises.GlobeNewswire Inc. · Oct 7, 2025

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross ProceedsMicrobot Medical raised $25.2 million in the first closing of a preferred investment option exercise, with potential additional gross proceeds of up to $92.2 million. The company plans to use the funds for developing its LIBERTY Robotic System, potential acquisitions, and general corporate purposes.GlobeNewswire Inc. · Sep 16, 2025

Microbot Medical Closes $13 Million Registered Direct OfferingMicrobot Medical Inc. announced the closing of a registered direct offering and concurrent private placement, raising approximately $13 million. The company plans to use the proceeds for the development, commercialization, and regulatory activities of its LIBERTY® Robotic System, as well as for working capital and other general corporate purposes.GlobeNewswire Inc. · Feb 11, 2025

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial - GlobeNewswireBaptist Hospital of Miami has completed its first clinical procedure using Microbot Medical's LIBERTY® Endovascular Robotic Surgical System, which is part of the company's pivotal human clinical trial. This is the second site to perform clinical procedures for the trial, which aims to support the future submission to the FDA for the commercialization of the system.GlobeNewswire Inc. · Jul 9, 2024

Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY - Zacks Investment ResearchMicrobot Medical has signed a clinical trial agreement with the Baptist Hospital of Miami for its LIBERTY Endovascular Robotic Surgical System. The trial has received Institutional Review Board approval, and the Baptist Hospital is the second site to participate in the clinical trial. The market for robotic-assisted endovascular systems is expected to grow significantly, and Microbot's LIBERTY system is well-positioned to capitalize on this opportunity.Zacks Investment Research · Jul 4, 2024

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical TrialFollowing FDA Approval to Commence the Clinical Trial, an Official Site Initiation Has Taken Place as Preparation for Patient Enrollment AdvancesGlobeNewswire Inc. · Jun 20, 2024

Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical TrialThe Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was deliveredGlobeNewswire Inc. · Jun 17, 2024

to start trading

MB

MBOTMicrobot Medical, Inc. Common Stock

MBOT

Pay with—

Available Balance0.00

Your PositionYou don't own any MBOT yet.

Related Tickers

Earnings